Categorizing tumors by cell type and not the organ they grow in may alter treatment, experts say
by dansgirl on Sat Feb 07, 2009 12:00 AM
by hundred on Fri Jan 08, 2010 07:42 AM
On Feb 07, 2009 12:00 AM dansgirl wrote: My husband was diagnosed with locally recurrent but inoperable ampullary adenocarcinoma in april '08 and has been through a failed course of oxaliplatin/cetuximab/xeloda and is now on irinotecan/avastan/5fu with radiographic stabilization. We've been offered a repeat course of radiation (was done as part of his initial adjunctive treatment regimen post-whipple), but we were told that it is almost never done, and the doctor couldn't give us any idea about either likelihood of success or risks of doing it. Does anyone have any experience with this?
On Feb 07, 2009 12:00 AM dansgirl wrote:
how is your husband doing?
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.